• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者筛状组织学模式的肿瘤学结局:系统评价和荟萃分析。

Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis.

机构信息

Urology Section, University of Catania, Catania, Italy.

Department of Urology, St Antonius Hospital, Utrecht, The Netherlands.

出版信息

Prostate Cancer Prostatic Dis. 2023 Dec;26(4):646-654. doi: 10.1038/s41391-022-00600-y. Epub 2022 Oct 10.

DOI:10.1038/s41391-022-00600-y
PMID:36216967
Abstract

BACKGROUND

Changes applied to the Prostate cancer (PCa) histopathology grading, where patients with cribriform patterns (CP) may be categorized as grade group 2 and could hypothetically be surveilled. However, CP has been associated with worse oncological outcomes. The aim of our study is to systematically review and meta-analyze the available evidence on CP in PCa patients.

METHODS

This analysis was registered on PROSPERO (CRD42022298473). We performed a systematic literature search of PubMed, EMBASE and Scopus using Medical Subject Headings (MeSH) indexes, keyword searches, and publication types until December 2021. The search terms included: "prostate", "prostate cancer" and "cribriform". We also searched reference lists of relevant articles. Eligible studies included published journal articles that provided quantitative data on the association between cribriform patterns at radical prostatectomy and the presence of extra-prostatic extension (EPE), seminal vesicle invasion (SVI), positive surgical margins (PSM), biochemical recurrence (BCR) or cancer specific mortality (CSM).

RESULTS

Overall, 31 studies were included for the quantitative analysis. All articles have been published during a span of 11 years (2011-2022) with a mean month of follow-up of 62.87 months. The mean quality of these studies, assessed with the Newcastle Ottawa Scale was 6.27. We demonstrated that CP was associated with greater risk of EPE (odds ratio [OR] 1.96; P < 0.0001), SVI (OR: 2.89; p < 0.01), and PSM (OR: 1.88; p < 0.0007). Our analyses showed that CP was associated with greater risk of BCR (hazard ratio [HR]: 2.14; p < 0.01) and of CSM (HR: 3.30, p < 0.01).

CONCLUSION

The presence of CP is associated with adverse pathology at radical prostatectomy and worse biochemical recurrence and cancer specific mortality. These results highlight the importance of a better pathologic report of CP to advise clinician for a strict follow-up in PCa patients.

摘要

背景

前列腺癌(PCa)组织病理学分级发生变化,具有筛状模式(CP)的患者可能被归类为 2 级,并可能被监测。然而,CP 与较差的肿瘤学结果相关。我们研究的目的是系统地回顾和荟萃分析 PCa 患者中 CP 的现有证据。

方法

该分析在 PROSPERO(CRD42022298473)上进行了注册。我们使用医学主题词(MeSH)索引、关键词搜索和出版物类型,在 PubMed、EMBASE 和 Scopus 上进行了系统的文献搜索,直到 2021 年 12 月。搜索词包括:“前列腺”、“前列腺癌”和“筛状”。我们还搜索了相关文章的参考文献列表。符合条件的研究包括提供了根治性前列腺切除术中筛状模式与前列腺外延伸(EPE)、精囊侵犯(SVI)、阳性手术切缘(PSM)、生化复发(BCR)或癌症特异性死亡率(CSM)之间关联的定量数据的已发表期刊文章。

结果

总体而言,有 31 项研究被纳入定量分析。所有文章均在 11 年内(2011-2022 年)发表,平均随访时间为 62.87 个月。使用纽卡斯尔-渥太华量表评估这些研究的平均质量为 6.27。我们表明,CP 与更高的 EPE 风险相关(优势比 [OR] 1.96;P<0.0001)、SVI(OR:2.89;p<0.01)和 PSM(OR:1.88;p<0.0007)。我们的分析表明,CP 与更高的 BCR 风险相关(风险比 [HR] 2.14;p<0.01)和 CSM 风险相关(HR:3.30,p<0.01)。

结论

CP 的存在与根治性前列腺切除术后不良病理相关,并且生化复发和癌症特异性死亡率更高。这些结果强调了更好地报告 CP 的重要性,以便为 PCa 患者的临床医生提供严格的随访建议。

相似文献

1
Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis.前列腺癌患者筛状组织学模式的肿瘤学结局:系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2023 Dec;26(4):646-654. doi: 10.1038/s41391-022-00600-y. Epub 2022 Oct 10.
2
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.评估非转移性前列腺癌中评估保留神经与不保留神经的根治性前列腺切除术的肿瘤学结局和数据质量的研究:系统评价。
Eur Urol Focus. 2022 May;8(3):690-700. doi: 10.1016/j.euf.2021.05.009. Epub 2021 Jun 17.
3
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.局限性和局部晚期前列腺癌的新辅助和辅助激素治疗
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
6
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.根治性前列腺切除术治疗非转移性前列腺癌的术者和医院手术量对肿瘤学和非肿瘤学结局影响的系统评价
Eur Urol. 2021 Nov;80(5):531-545. doi: 10.1016/j.eururo.2021.04.028. Epub 2021 May 5.
7
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
8
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.嵌合抗原受体 (CAR) T 细胞疗法治疗复发或难治性弥漫性大 B 细胞淋巴瘤患者。
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
9
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
10
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.

引用本文的文献

1
Age-Specific Impact of Cribriform Pattern in Prostate Cancer Following Radical Prostatectomy.前列腺癌根治术后筛状模式的年龄特异性影响
Clin Med Insights Oncol. 2025 Aug 9;19:11795549251363324. doi: 10.1177/11795549251363324. eCollection 2025.
2
Comparison of , lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case-control prospective study (COMP study).番茄红素、硒与度他雄胺治疗下尿路症状/良性前列腺增生的比较:一项意大利多中心病例对照前瞻性研究(COMP研究)
Front Urol. 2025 Apr 25;5:1565240. doi: 10.3389/fruro.2025.1565240. eCollection 2025.
3
Link between multiple human papillomavirus 16 and 18 infection and prostate cancer, and relevance of tumor characteristics.

本文引用的文献

1
Current conundrums with cribriform prostate cancer.筛状前列腺癌的当前难题
Histopathology. 2022 Jun;80(7):1038-1040. doi: 10.1111/his.14665.
2
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.筛状结构在预测 2 级前列腺癌患者的结局方面优于 Gleason 模式 4 百分比和三级 Gleason 模式 5。
Histopathology. 2022 Feb;80(3):558-565. doi: 10.1111/his.14590. Epub 2021 Dec 14.
3
PTEN expression and morphological patterns in prostatic adenocarcinoma.
多种人乳头瘤病毒16型和18型感染与前列腺癌之间的联系以及肿瘤特征的相关性。
Mol Clin Oncol. 2025 Jul 11;23(3):85. doi: 10.3892/mco.2025.2880. eCollection 2025 Sep.
4
Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer.筛状模式对 Gleason 评分 8 - 10 分前列腺癌根治术后无进展生存期的影响
Eurasian J Med. 2025 Apr 21;57(1):1-5. doi: 10.5152/eurasianjmed.2025.25804.
5
Intermediate risk prostate tumors contain lethal subtypes.中度风险前列腺肿瘤包含致死性亚型。
Front Urol. 2024;4. doi: 10.3389/fruro.2024.1487873. Epub 2025 Jan 14.
6
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.前列腺癌的组织病理学评估和分级:当前的问题和关键方面。
Asian J Androl. 2024 Nov 1;26(6):575-581. doi: 10.4103/aja202440. Epub 2024 Sep 10.
7
GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer.GRIN3A:与前列腺癌筛状模式和预后不良相关的生物标志物。
Neoplasia. 2024 Sep;55:101023. doi: 10.1016/j.neo.2024.101023. Epub 2024 Jun 29.
8
Cribiform and intraductal carcinoma in hereditary prostate cancer: clinical and pathological analysis of 20 cases.遗传性前列腺癌中的筛状癌和导管内癌:20例临床病理分析
Am J Clin Exp Urol. 2024 Apr 15;12(2):100-109. doi: 10.62347/XOIN3964. eCollection 2024.
9
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study).CYP7B1 作为前列腺癌风险和进展的生物标志物:代谢和致癌特征(前列腺癌患者组织微阵列的免疫组织化学分析-钻石研究)。
Int J Mol Sci. 2024 Apr 27;25(9):4762. doi: 10.3390/ijms25094762.
10
Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations.前列腺癌筛状模式的预后意义:临床结局与基因组改变
Cancers (Basel). 2024 Mar 22;16(7):1248. doi: 10.3390/cancers16071248.
前列腺腺癌中的 PTEN 表达和形态模式。
Histopathology. 2021 Dec;79(6):1061-1071. doi: 10.1111/his.14531. Epub 2021 Sep 12.
4
ISUP Consensus Definition of Cribriform Pattern Prostate Cancer.ISUP 共识定义的筛状前列腺癌模式。
Am J Surg Pathol. 2021 Aug 1;45(8):1118-1126. doi: 10.1097/PAS.0000000000001728.
5
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
PLoS Med. 2021 Mar 29;18(3):e1003583. doi: 10.1371/journal.pmed.1003583. eCollection 2021 Mar.
6
Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.前列腺活检中筛状生长和 4 级成分比例对 Gleason 评分 3+4 肿瘤的比较影响。
Ann Diagn Pathol. 2021 Jun;52:151725. doi: 10.1016/j.anndiagpath.2021.151725. Epub 2021 Feb 16.
7
Prognostic significance of architectural subtypes of Gleason grade 4 prostate cancer in radical prostatectomy: A semiquantitative method of evaluation.根治性前列腺切除术中 Gleason 4 级前列腺癌结构亚型的预后意义:一种半定量评估方法。
Ann Diagn Pathol. 2021 Feb;50:151678. doi: 10.1016/j.anndiagpath.2020.151678. Epub 2020 Dec 13.
8
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
9
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.在前列腺癌 Gleason 评分 8 分的患者中,根治性前列腺切除术中的筛状结构可预测肿瘤学结局。
Mod Pathol. 2021 Jan;34(1):184-193. doi: 10.1038/s41379-020-0625-x. Epub 2020 Jul 20.
10
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会(ISUP)前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.